Onego Bio
Onego Bio is a Finnish food-biotech company producing Bioalbumen®, a precision-fermented animal-free ovalbumin ingredient. It sells B2B to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives, targeting the $330B global egg market.
- Company typePrivate
- Founded2022
- HeadquartersHelsinki, Finland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Onego Bio does
Onego Bio is a Finnish food-biotech company founded in 2022 as a spin-out from VTT Technical Research Centre of Finland. It produces Bioalbumen®, a precision-fermented animal-free ovalbumin (egg white protein) ingredient marketed to industrial food manufacturers. The company operates a B2B ingredient supplier model, selling exclusively to commercial customers such as bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies, rather than to end consumers. Revenue mechanics are quote-based B2B contracts with multi-year cadence, supported by R&D services including recipe optimization, shelf-life testing, and functional validation through its San Diego test kitchen.
The company's core technology is a proprietary Trichoderma reesei microbial platform exclusively licensed from VTT, designed to produce ovalbumin via precision fermentation at industrial scale. The platform has demonstrated 120 g/L productivity in 250,000 L fermentation vessels, and the planned Wisconsin flagship facility targets 2 million liters of fermentation capacity, equivalent to the protein output of 6 million laying hens per unit. Bioalbumen® is functionally bioidentical to conventional egg white protein, delivering all essential amino acids with a PDCAAS score of 1.0, complete functional performance (foaming, gelling, binding, emulsification), and a 2-year ambient shelf life, with company-estimated environmental footprint reductions of 95% in land use, 72-89% in greenhouse gas emissions, and 87-89% in water consumption versus conventional eggs.
As of the input data, Onego Bio is in pre-commercialization to early commercialization phase. It received FDA GRAS 'no questions' status for Bioalbumen® in September 2025 (GRN 1249), enabling U.S. market entry, and is collaborating with over 25 named CPG companies on product formulation. The company maintains R&D operations in Helsinki, U.S. commercial headquarters in San Diego opened September 2024, and is building a flagship manufacturing facility in Jefferson County, Wisconsin targeted for 2028 operations, while scaling current supply via co-manufacturers.
Onego Bio firmographics
Firmographics- Name
- Onego Bio
- Legal name
- Onego Bio Ltd
- Website
- https://onego.bio
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Onego Bio is a Finnish food-biotech company producing Bioalbumen®, a precision-fermented animal-free ovalbumin ingredient. It sells B2B to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives, targeting the $330B global egg market.
- Ownership category
- akta.pro rank
Onego Bio industry classification
Industry- Product category
- Precision Fermented Egg Protein Ingredients
- SIC
- Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation) (AFAKAGAH)
Keywords
Where Onego Bio is headquartered
LocationHeadquarters
- HQ city
- Helsinki
- HQ country
- Finland
- HQ region
- Europe
Offices3 records
Markets served
Onego Bio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Bioalbumen Ingredient Sales: Sale of precision-fermented egg protein (Bioalbumen) as a food ingredient to commercial food manufacturers including bakeries, confectionery producers, snack manufacturers, sauce makers, pasta producers, and meat alternative companies. Sold as a B2B ingredient rather than consumer product. The company provides R&D support including recipe optimization, shelf-life testing, and functional performance validation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient pricing for food manufacturers |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Onego Bio product offering
Product offeringCore offering
Onego Bio manufactures and sells Bioalbumen®, an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. The product is sold as a B2B food ingredient to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternative categories, providing identical taste, nutrition, and functional properties to conventional egg protein with significantly reduced environmental footprint and supply chain stability.
Product overview
Onego Bio is a US-Finnish food-biotech company with a single flagship product: Bioalbumen®, an animal-free egg white protein ingredient produced via precision fermentation using Trichoderma reesei. The company operates as a B2B ingredient supplier, targeting food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternatives sectors. Bioalbumen® provides the same functional, nutritional, and sensory performance as traditional eggs while offering supply stability, price predictability, and significantly reduced environmental impact. The product is currently in commercialization phase with FDA GRAS status achieved and manufacturing facility planned in Jefferson County, Wisconsin.
Differentiator
Problem solved
Functional benefit
Brands
- Bioalbumen®: Precision-fermented animal-free egg white protein powder that provides identical functionality, nutrition, and taste to conventional egg white protein with approximately 90% smaller environmental footprint.
Products and services
- Bioalbumen® Bioalbumen® is an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. It delivers identical taste, nutrition (PDCAAS 1.0, 90+ g protein per 100 g), and functional properties (foaming, gelling, binding, emulsification) to conventional egg white protein. Sold as a B2B food ingredient to commercial food manufacturers in baked goods, confectionery, snacks, beverages, sauces, pasta, meat alternatives, and ready-made meals. Features 24-month ambient shelf life, eliminating cold chain requirements, with 95% less land use, 72-89% fewer GHG emissions, and 89% less water consumption compared to traditional eggs.
Quantifiable outcome
- 95% less land use, 89% fewer GHG emissions, 89% less water consumption vs conventional eggs
- +3 more outcomes
Companies that use Onego Bio
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Onego Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Onego Bio partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Sigma FoodscoreCollaboration agreement to evaluate Bioalbumen functionality and commercial potential in commercially relevant food products. Partnership focuses on addressing egg supply chain challenges including volatility, rising prices, and avian flu disruptions. Includes feasibility assessments, prototype development, and application trials.
- Jefferson County Food and Beverage Innovation CampuscoreSite partner for flagship manufacturing facility. Company is second tenant at campus located in Jefferson County, Wisconsin. $777,000 land purchase of 25.9 acres approved by Jefferson County Board.
- Food Fermentation EuropeminorFounding member together with Better Dairy, Formo, Imagindairy, and Those Vegan Cowboys. European alliance working toward forward-looking regulatory environment for sustainable animal-free foods.
- Precision Fermentation AllianceminorFounding member together with Change Foods, The EVERY Co., Helaina, Imagindairy, Motif FoodWorks, New Culture, Perfect Day, and Remilk. Industry coalition to champion precision fermentation as trusted solution for sustainable food system.
- nth Bio (Perfect Day)coreEnterprise biology partnership providing strain engineering, bioprocess development, regulatory support, and scale-up process services. nth Bio (formerly Perfect Day's enterprise biology division) offers end-to-end expertise from molecular development to commercial-scale manufacturing.
- VTT Technical Research Centre of FinlandcoreSpin-out origin and technology licensor. Company acquired license to Trichoderma reesei technology developed at VTT for precision fermentation of egg proteins. VTT LaunchPad science-based spin-off incubator supported company formation.
Scale indicators12 records
Recent moves9 records
Expansion highlights8 records
Onego Bio competitors and assessment
Company assessmentDirect peers
- The EVERY Company: The EVERY Company (formerly Clara Foods) is the most direct competitor, producing animal-free egg proteins via precision fermentation for food and beverage manufacturers. Overlap with Onego is near-complete in product category (precision-fermented egg white protein) and target customer base (industrial food manufacturers), making it the closest comparable for technology, customer adoption, and regulatory benchmarks.
Broad incumbents
- Perfect Day: Perfect Day is one of the largest precision fermentation food companies, producing animal-free whey protein for dairy applications. It is a broader incumbent (dairy rather than egg) but uses the same core precision fermentation platform and B2B ingredient business model, and has historically partnered with Onego via its enterprise biology arm.
- Remilk: Remilk produces animal-free dairy proteins via precision fermentation and operates a B2B ingredient model selling to food manufacturers. While focused on beta-lactoglobulin (dairy) rather than ovalbumin, it shares the precision fermentation production architecture, regulatory pathway, and CPG customer base.
- Motif FoodWorks: Motif FoodWorks is a precision fermentation food ingredient company developing animal-free proteins and fats for plant-based meat and dairy alternatives. It shares the precision fermentation B2B ingredient model and large-scale fermentation capacity build-out, though its portfolio is broader and aimed at alternative protein applications.
- Eat Just (JUST Egg): Eat Just's JUST Egg brand is the most established commercial alternative to eggs, using mung bean protein rather than precision fermentation. It targets the same end-use cases (scrambled egg, baking, mayonnaise) and the same CPG customer base, making it a relevant commercial benchmark for the egg-alternative category.
Emerging players
- Imagindairy: Imagindairy produces precision-fermented non-animal dairy proteins targeting the bakery, ice cream, and cheese markets. It overlaps with Onego in production technology (precision fermentation) and the target use cases (functional protein ingredients for industrial bakeries and food manufacturers) but operates in dairy rather than egg protein.
- New Culture: New Culture produces animal-free casein proteins for cheese via precision fermentation. It shares production technology and a B2B ingredient model selling to food manufacturers, but is focused on dairy cheese proteins rather than egg white proteins.
- Change Foods: Change Foods is developing animal-free cheese proteins via precision fermentation. As a fellow founding member of the Precision Fermentation Alliance, it shares technology, regulatory pathway considerations, and the B2B ingredient model with Onego, though its target protein is dairy casein.
- Better Dairy: Better Dairy is a precision fermentation company producing animal-free dairy proteins (cheese and butterfat). As a fellow founding member of Food Fermentation Europe alongside Onego, it shares technology, regulatory advocacy, and the B2B ingredient model but operates in dairy.
- Those Vegan Cowboys: Those Vegan Cowboys is developing animal-free dairy proteins via precision fermentation. Co-founded Food Fermentation Europe with Onego, sharing the precision fermentation production model and European regulatory advocacy, though its target protein is dairy rather than egg.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Onego Bio social profiles
Digital presenceOnego Bio compliance and trust
Trust signalCompliance2 records
Onego Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Onego Bio leadership team
Management profileNumber of profiles
Profiles5 records
Onego Bio funding detail
Funding detailFunding overview
Funding rounds8 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Onego Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Onego Bio
What does Onego Bio do?
Onego Bio manufactures and sells Bioalbumen®, an animal-free egg white protein (ovalbumin) powder produced through precision fermentation using the proprietary Trichoderma reesei microbial platform. The product is sold as a B2B food ingredient to commercial food manufacturers in bakery, confectionery, snacks, sauces, pasta, and meat alternative categories, providing identical taste, nutrition, and functional properties to conventional egg protein with significantly reduced environmental footprint and supply chain stability.
Is Onego Bio a public or private company?
Onego Bio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Onego Bio founded?
Onego Bio was founded in 2022. It employs 51 to 100 people.
Where is Onego Bio based?
Onego Bio is headquartered in Helsinki, Finland, in the Europe region.
How does Onego Bio make money?
One revenue line is on record: bioalbumen Ingredient Sales.
Who are Onego Bio's main competitors?
The EVERY Company is listed as a direct peer. Broad incumbents are Perfect Day, Remilk, Motif FoodWorks and Eat Just (JUST Egg). Emerging players are Imagindairy, New Culture, Change Foods, Better Dairy and Those Vegan Cowboys.
Does Onego Bio have an API?
No public API is recorded for Onego Bio.
What industry is Onego Bio in?
Onego Bio's product category is Precision Fermented Egg Protein Ingredients. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation). Its SIC code is 2000.